The Role of Arterial Hypertension in Mitral Valve Regurgitation

[1]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[2]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[3]  A. Kobori,et al.  Renin-angiotensin system inhibitors in patients with or without ischaemic mitral regurgitation after acute myocardial infarction , 2017, Open Heart.

[4]  Terence Dwyer,et al.  Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults , 2017, PLoS medicine.

[5]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[6]  S. Söderberg,et al.  Traditional Cardiovascular Risk Factors and Their Relation to Future Surgery for Valvular Heart Disease or Ascending Aortic Disease: A Case–Referent Study , 2017, Journal of the American Heart Association.

[7]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[8]  K. Reynolds,et al.  Global Disparities of Hypertension Prevalence and ControlClinical Perspective , 2016 .

[9]  N. Sato,et al.  Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction , 2016, European journal of heart failure.

[10]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[11]  C. Lam,et al.  Heart failure with preserved ejection fraction in hypertension , 2016, Current opinion in cardiology.

[12]  R. Siegel,et al.  The Role of Medical Therapy in Moderate to Severe Degenerative Mitral Regurgitation. , 2016, Reviews in cardiovascular medicine.

[13]  Kiyoshi Yoshida,et al.  Renin–angiotensin system inhibitors in patients with myocardial infarction and secondary mitral regurgitation , 2016, Heart.

[14]  Sudha Seshadri,et al.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study , 2015, The Lancet.

[15]  E. Herrold,et al.  Relation of Indirect Vasodilator Use to Prognosis in Patients with Chronic Severe Mitral Regurgitation , 2014, Cardiology.

[16]  Nancy M Albert,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.

[17]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[18]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[19]  S. Armstrong,et al.  Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: a 25-year experience. , 2013, The Journal of thoracic and cardiovascular surgery.

[20]  P. Pibarot,et al.  Secondary Mitral Regurgitation in Heart Failure with Reduced or Preserved Left Ventricular Ejection Fraction , 2013, Cardiology.

[21]  G. Filippatos,et al.  [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.

[22]  Sean M. O'Brien,et al.  Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. , 2012, The Annals of thoracic surgery.

[23]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[24]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[25]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[26]  T. Denney,et al.  A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation. , 2012, Journal of the American College of Cardiology.

[27]  S. Duval,et al.  Pharmacotherapy in the treatment of mitral regurgitation: a systematic review. , 2012, The Journal of heart valve disease.

[28]  T. Denney,et al.  Left ventricular remodeling in preclinical experimental mitral regurgitation of dogs. , 2012, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

[29]  M. Keane,et al.  Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. , 2011, Journal of the American College of Cardiology.

[30]  J. Oh,et al.  Atrioventricular Reverse Remodeling After Valve Repair for Chronic Severe Mitral Regurgitation: 1‐Year Follow‐Up , 2010, Clinical cardiology.

[31]  F. Aslam,et al.  The Frequency and Functional Impact of Overlapping Hypertension on Hypertrophic Cardiomyopathy: A Single‐Center Experience , 2010, Journal of clinical hypertension.

[32]  J. J. Rivera,et al.  Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2010, Atherosclerosis.

[33]  P. Pibarot,et al.  Elevated left atrial pressure estimated by Doppler echocardiography is a key determinant of mitral valve tenting in functional mitral regurgitation , 2010, Heart.

[34]  D. Glower,et al.  Pure annular dilation as a cause of mitral regurgitation: a clinically distinct entity of female heart disease. , 2009, The Journal of heart valve disease.

[35]  L. Lai,et al.  Rupture of mitral chordae tendineae: adding to the list of hypertension complications , 2009, Heart.

[36]  T. Henry,et al.  Practice variation among cardiovascular physicians in management of patients with mitral regurgitation. , 2009, The American journal of cardiology.

[37]  B. Cowan,et al.  Pilot Study to Assess the Influence of &bgr;-Blockade on Mitral Regurgitant Volume and Left Ventricular Work in Degenerative Mitral Valve Disease , 2008, Circulation.

[38]  P. Varadarajan,et al.  Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction. , 2008, The American journal of cardiology.

[39]  Harlan M Krumholz,et al.  ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  Harlan M Krumholz,et al.  ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[41]  B. Carabello.  The current therapy for mitral regurgitation. , 2008, Journal of the American College of Cardiology.

[42]  T. Tavlı,et al.  Effect of losartan on exercise tolerance and echocardiographic parameters in patients with mitral regurgitation , 2008, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[43]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[44]  D. Meyers,et al.  Afterload Reduction May Halt and Beta-Adrenergic Blockade May Worsen Progression of Left Ventricular Dysfunction in Patients With Chronic Compensated Mitral Regurgitation: A Retrospective Cohort Study , 2007, Angiology.

[45]  Ramin Ebrahimi,et al.  Mitral Annulus Calcification is associated with valvular and cardiac structural abnormalities , 2007, Cardiovascular ultrasound.

[46]  J. Borer,et al.  The epidemiology of valvular heart disease: a growing public health problem. , 2006, Heart failure clinics.

[47]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[48]  Jeroen J. Bax,et al.  Mitral regurgitation and left ventricular dyssynchrony: implications for treatment , 2006, Heart.

[49]  M. Schemper,et al.  Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation , 2006, Circulation.

[50]  L. Rudski,et al.  Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral regurgitation. , 2006, The Canadian journal of cardiology.

[51]  D. Aeppli,et al.  Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity. , 2005, American heart journal.

[52]  C. Mady,et al.  Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease. , 2005, The American journal of cardiology.

[53]  L. Coombs,et al.  Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. , 2004, The Annals of thoracic surgery.

[54]  V. Palmieri,et al.  Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study , 2004, Journal of Human Hypertension.

[55]  H. Oral,et al.  Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation. , 2004, American heart journal.

[56]  P. Hildebrandt,et al.  Pre- and afterload reduction in chronic mitral regurgitation: a double-blind randomized placebo-controlled trial of the acute and 2 weeks' effect of nifedipine or isosorbide dinitrate treatment on left ventricular function and the severity of mitral regurgitation. , 2003, British journal of clinical pharmacology.

[57]  H. Oral,et al.  Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. , 2003, American heart journal.

[58]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[59]  L. Dell’Italia.  The renin-angiotensin system in mitral regurgitation: A typical example of tissue activation , 2002, Current cardiology reports.

[60]  M. Kohno,et al.  Prevention of Cerebral Thromboembolism by Low-Dose Anticoagulant Therapy in Atrial Fibrillation with Mitral Regurgitation , 2001, Journal of cardiovascular pharmacology.

[61]  M. Enriquez-Sarano,et al.  Effect of losartan on degree of mitral regurgitation quantified by echocardiography. , 2001, The American journal of cardiology.

[62]  N. Sinha,et al.  Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study. , 2001, The Journal of heart valve disease.

[63]  Y. Adler,et al.  Mitral annulus calcification--a window to diffuse atherosclerosis of the vascular system. , 2001, Atherosclerosis.

[64]  B V Howard,et al.  Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). , 2001, The American journal of cardiology.

[65]  P. Grayburn.  Vasodilator therapy for chronic aortic and mitral regurgitation. , 2000, The American journal of the medical sciences.

[66]  P. Grayburn.  Southwestern Internal Medicine Conference: Vasodilator Therapy for Chronic Aortic and Mitral Regurgitation , 2000 .

[67]  A. Mortara,et al.  β-Blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol , 2000 .

[68]  P. Kligfield,et al.  Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery. , 2000, The American journal of cardiology.

[69]  A J Tajik,et al.  Progression of mitral regurgitation: a prospective Doppler echocardiographic study. , 1999, Journal of the American College of Cardiology.

[70]  W. Abraham,et al.  Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. , 1999, The American journal of cardiology.

[71]  Jagmeet P. Singh,et al.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) , 1999, The American journal of cardiology.

[72]  T. Levine,et al.  Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. , 1998, The American journal of cardiology.

[73]  P. Grayburn,et al.  Effects of afterload reduction on vena contracta width in mitral regurgitation. , 1998, Journal of the American College of Cardiology.

[74]  M. LeWinter,et al.  Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse. , 1998, The American journal of cardiology.

[75]  J. Lodder,et al.  Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve , 1997, Heart.

[76]  P. Hildebrandt,et al.  Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse. , 1997, The American journal of cardiology.

[77]  S. Keteyian,et al.  Reverse remodeling in heart failure with intensification of vasodilator therapy , 1997, Clinical cardiology.

[78]  J. Mccans,et al.  Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. , 1997, The Canadian journal of cardiology.

[79]  W. Gaasch,et al.  Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. , 1996, Journal of the American College of Cardiology.

[80]  R. Pai,et al.  Effect of isolated left atrial enlargement on mitral annular size and valve competence. , 1996, The American journal of cardiology.

[81]  M. Enriquez-Sarano,et al.  Echocardiographic Prediction of Survival After Surgical Correction of Organic Mitral Regurgitation , 1994, Circulation.

[82]  G. A. Moore,et al.  Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. , 1994, British heart journal.

[83]  H. Schön.  Hemodynamic and morphologic changes after long‐term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[84]  T. Wisenbaugh,et al.  Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. , 1994, The Journal of heart valve disease.

[85]  S. Gentile,et al.  Slowing of mitral valve annular calcium in systemic hypertension by nifedipine and comparisons with enalapril and atenolol. , 1993, The American journal of cardiology.

[86]  M. Starling,et al.  Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. , 1993, Journal of the American College of Cardiology.

[87]  M. Woo,et al.  Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. , 1991, The American journal of cardiology.

[88]  S. Senda,et al.  Evaluation of left-sided valvular regurgitation in healthy, hypertensive and myocardial infarction subjects by Doppler echocardiography. , 1990, Japanese circulation journal.

[89]  M. Schwaiger,et al.  Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1987, The American journal of cardiology.

[90]  O. Hess,et al.  The relationship of afterload to ejection performance in chronic mitral regurgitation. , 1987, Circulation.

[91]  W. Aronow,et al.  Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility. , 1987, The American journal of cardiology.

[92]  S. R. Cohen,et al.  Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.

[93]  S. Reske,et al.  [Reduction of regurgitation in aortic and mitral insufficiency by captopril in acute and long-term trials]. , 1985, Schweizerische medizinische Wochenschrift.

[94]  S. Reske,et al.  Captopril-induced reduction of regurgitation fraction in aortic insufficiency: Acute and long-term effects , 1985 .

[95]  J. Spann,et al.  Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. , 1984, Journal of the American College of Cardiology.

[96]  W. Kannel,et al.  Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study). , 1983, The American journal of cardiology.

[97]  S. Rahimtoola,et al.  Arterial Dilators in Mitral Regurgitation: Effects on Rest and Exercise Hemodynamics and Long‐term Clinical Follow‐up , 1982, Circulation.

[98]  B. Brundage,et al.  Beneficial Effects of Hydralazine in Severe Mitral Regurgitation , 1978, Circulation.

[99]  W. Grossman,et al.  Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. , 1975, Annals of internal medicine.

[100]  D. Harrison,et al.  Effect of Nitroprusside on Left Ventricular Dynamics in Mitral Regurgitation , 1974, Circulation.

[101]  W. Parmley,et al.  Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus , 1973, Circulation.

[102]  A. D. Jose,et al.  THE INFLUENCE OF ARTERIAL PRESSURE ON MITRAL INCOMPETENCE IN MAN. , 1964, The Journal of clinical investigation.

[103]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[104]  S. Choo,et al.  Echocardiographic evaluation of mitral durability following valve repair in rheumatic mitral valve disease: impact of Maze procedure. , 2014, The Journal of thoracic and cardiovascular surgery.

[105]  Helmut Baumgartner,et al.  The 2013 ESH/ESC guidelines for the management of arterial hypertension , 2013 .

[106]  B. Gersh,et al.  ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[107]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[108]  M. Enriquez-Sarano,et al.  Does early surgical intervention improve left ventricular mass regression after mitral valve repair for leaflet prolapse? , 2011, The Journal of thoracic and cardiovascular surgery.

[109]  M. Schluchter,et al.  Prevalence of unsuspected and significant mitral and aortic regurgitation. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[110]  Ho-Ming Su,et al.  Association between hypertension and primary mitral chordae tendinae rupture. , 2006, American journal of hypertension.

[111]  M. Starling.  Emerging biology of mitral regurgitation: implications for further therapy. , 2002, Advances in cardiology.

[112]  A. Mortara,et al.  Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. , 2000, American heart journal.

[113]  A. Zanchetti,et al.  Prevalence of physiological valvular regurgitation in hypertensive patients: echocardiographic and color Doppler study. , 1992, Cardiology.

[114]  M. Schwaiger,et al.  Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. , 1990, Journal of the American College of Cardiology.

[115]  A. Walker,et al.  The vascular system. , 1952, Progress in neurology and psychiatry.

[116]  R GORLIN,et al.  Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. , 1951, American heart journal.